Search clinical trials for: Machine learning algorithm

Total 10000 results

Hipra Scientific, S.L.U

Completed

A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain, Italy
University of Iowa
University of Minnesota

Completed

Precision-Based Approach to Matching Evidence-Based Interventions to Students With Externalizing Behaviors (SIMSRCT)

Problem;Behaviour;Child

United States
ImmunityBio, Inc.

Completed

COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers

COVID-19

United States
University of Debrecen

Completed

Serology After BBIBP-CorV Inactivated Vaccine Combined With BNT62b2 mRNA Booster Vaccine

Basic BBIBP-CorV Vaccination is Not as Effective as BNT162b

Hungary
Merck Sharp & Dohme LLC

Completed

Hepatitis B Challenge Dose in Adults (V232-059-10)

Hepatitis B
Novavax

Completed

Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

Respiratory Syncytial Virus (RSV)

United States
PT Bio Farma
Sinovac Life Sciences Co., Ltd.; Faculty of Medicine Universitas Padjadjaran; National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia

Completed

Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine (COVID-19)

SARS-CoV2 Infection

Indonesia
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

HIV Infections | H1N1 Influenza Virus

United States, Puerto Rico
Chinese University of Hong Kong

Completed

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

Nasopharyngeal Cancer | Epstein-Barr Virus Infections

Hong Kong
D'Or Institute for Research and Education
Butantan Institute

Active, not recruiting

A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19

COVID-19

Brazil
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns

Covid19 | Vaccine Reaction | Coronavirus | Menstrual Problem | Endometrium

Turkey
Novartis Pharmaceuticals

Completed

A Phase I Study of Oral BGJ398 in Asian Patients

Tumor With Alterations of the FGF-R

China, Japan
University of British Columbia
University of California, San Diego; Vanderbilt University; Institut Pasteur; J... and other collaborators

Completed

Immunity to Hepatitis B Vaccine (HVP01)

Hepatitis B | Immunization; Infection

Canada
Research Institute for Biological Safety Problems
Research Institute of Influenza, Russia; Ministry of Health, Kazakhstan

Completed

Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine

Tuberculosis
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH)

Completed

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

Melanoma (Skin)

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer

Breast Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

DC Vaccine for Patients With Ductal Carcinoma In Situ (DCIS6)

Breast Cancer | DCIS

United States
University of Bergen
Haukeland University Hospital

Completed

Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen (H1N1VAC)

Healthy

Norway
GlaxoSmithKline

Completed

Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study

Meningococcal Disease | Infections, Meningococcal

United States
National Institute of Allergy and Infectious Diseases...

Completed

H5N1 Vaccination With and Without AS03: Systems Biology Analysis

Influenza

United States
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Mix Vaccine for Metastatic Sarcoma Patients

Metastatic Sarcoma | Reaction - Mixed Vaccine

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Mix Vaccine for Metastatic Kidney Cancer

Metastasis From Malignant Tumor of Kidney (Disorder) | Reaction - Mixed Vaccine

China
University of Oxford
Medical Research Council; Ifakara Health Institute

Completed

Safety and Immunogenicity of ChAd63 RH5 and MVA RH5 in Adults, Young Children and Infants Living in Tanzania

Malaria,Falciparum

Tanzania
Pfizer

Completed

A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age

Group B Streptococcal Infections

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

Herpes Zoster | Shingles
Boehringer Ingelheim

Terminated

Multiple Rising Dose of BI 1181181 Given Orally in Young Healthy Male and Elderly Healthy Male/Female Volunteers

Healthy

Germany
National Institute of Allergy and Infectious Diseases...

Completed

H7N9 Boost in Healthy Adults

Influenza

United States
GlaxoSmithKline

Completed

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

Influenza

Canada
GlaxoSmithKline

Completed

Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

Influenza

Germany, United States, Belgium, Norway
GlaxoSmithKline

Completed

Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix

Influenza

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A

Influenza

Germany, Sweden, United Kingdom, Netherlands
GlaxoSmithKline

Completed

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects

Infections, Meningococcal

Taiwan, Philippines, India
GlaxoSmithKline

Completed

Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older

Herpes Zoster

United States
GlaxoSmithKline

Completed

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

AIDS

Spain, Germany, France, United States
Tan Tock Seng Hospital
National Healthcare Group, Singapore; Singapore Immunology Network

Unknown

Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial

Diabetes Mellitus | Immune Response | Vitamin D Deficiency | Elderly | Influenza Vaccine | Metabolic Disease

Singapore
Topokine Therapeutics, Inc.

Completed

Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)

Steatoblepharon

United States
Ain Shams University

Completed

Role of Human Leukocyte Antigen Matching in Liver Transplantation and Its Relation to Outcomes

Liver Transplantation
Khon Kaen University

Unknown

Spot Marching Exercise Test in Chronic Obstructive Pulmonary Disease (SMT)

Pulmonary Disease, Chronic Obstructive

Thailand
GlaxoSmithKline

Completed

Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612

Infections, Meningococcal

Denmark
Sanofi Pasteur, a Sanofi Company

Completed

Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants

Hepatitis B | Pertussis | Diphtheria | Polio

Turkey
Rockefeller University
Memorial Sloan Kettering Cancer Center

Completed

Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer

Prostate Cancer

United States
Sanaria Inc.
Swiss Tropical & Public Health Institute; Ifakara Health Institute; Hospital... and other collaborators

Completed

Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults

Malaria | Plasmodium Falciparum

Equatorial Guinea
International Vaccine Institute
EuBiologics Co.,Ltd

Unknown

Safety and Immunogenicity of a New Formulation of Euvichol®

Cholera
Sinovac Biotech Co., Ltd

Completed

The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine

Influenza

China
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

Neoplasms, Pancreas

China
Pfizer

Completed

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Encephalitis, Tick-borne

Austria, Germany
Pfizer

Completed

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Encephalitis, Tick-borne

Austria
Pfizer

Completed

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Encephalitis, Tick-borne

Poland
University of Manitoba
Inovio Pharmaceuticals

Completed

DNA-based Influenza Vaccine in the Elderly

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Influenza, Human | Orthomyxoviridae Infections

Canada
GlaxoSmithKline
United States Department of Health and Human Services, Center for Disease...

Withdrawn

Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Influenza

United States

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations